Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 2

Status

Recruiting 8Active not recruiting 7Completed 6Unknown 3Withdrawn 1Terminated 1

Sponsor Class

OTHER 77INDUSTRY 40NIH 12NETWORK 7

Study Type

Interventional 7

Sponsor

Cancer Type

Plasma cell 6Lymphoid 1

Conditions

Multiple Myeloma 6Lymphoma, Mantle-Cell 1Lymphoma 1

Interventions

Specimen Handling 19Cyclophosphamide 18Magnetic Resonance Spectroscopy 17Vincristine 16Dexamethasone 15Radiotherapy 14Cisplatin 14Radiation 12Etoposide 11Doxorubicin 11Radiotherapy, Intensity-Modulated 10Carboplatin 10durvalumab 9Paclitaxel 9Cytarabine 8Temozolomide 7Rituximab 7Radiotherapy, Conformal 7Prednisone 7Lenalidomide 7Irinotecan 7Gemcitabine 7Fluorouracil 7Docetaxel 7Bortezomib 7Biopsy 7daratumumab 6Platinum 6Leucovorin 6Capecitabine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Active not recruiting × NETWORK × Lenalidomide × Clear all
NCT05257083 2026-03-17

CARTITUDE-6

European Myeloma Network B.V.

Phase 3 Active not recruiting
759 enrolled
Plasma cell

Multiple Myeloma

NCT03710603 2026-02-10

Perseus

European Myeloma Network B.V.

Phase 3 Active not recruiting
709 enrolled 17 charts 1 FDA
Plasma cell

Multiple Myeloma

NCT04071457 2025-09-15

DRAMMATIC

SWOG Cancer Research Network

Phase 3 Active not recruiting
1,100 enrolled
Plasma cell

Multiple Myeloma

NCT01863550 2025-09-08

Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
1,087 enrolled
Plasma cell

Multiple Myeloma

NCT05123131 2025-07-08

Isa-RVD

Cancer Trials Ireland

Phase 2 Active not recruiting
54 enrolled
Plasma cell

Multiple Myeloma

NCT01415752 2025-04-08

Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
373 enrolled 14 charts
Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

NCT04934475 2024-11-07

MIDAS

Intergroupe Francophone du Myelome

Phase 3 Active not recruiting
791 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡